Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Approvals/Health Canada/KUVAN

Authorized

STANDARD

KUVAN

Biomarin International Limited🇨🇦 Health Canada

Approval Date: Jul 4, 2025
Approval ID: c12f04551fae8433
Company: Biomarin International Limited
Type: Standard

Approval Details

Approval Id: c12f04551fae8433
Drug Approval Canada Name: KUVAN
Product Name: KUVAN
Status: Marketed
Status Date: 2019-12-05
Original Market Date: 2019-12-05
Din: 02482207
Drug Class: Human
Dosage Form: Powder
Route Of Administration: Oral
Schedule: Prescription
Ahfs: 92:92.00
Atc Original: A16AX07 SAPROPTERIN
Atc Name: a 16 ax 07
Aig Number: 0152714001
Company Name: Biomarin International Limited
Company Address: Shanbally, Ringaskiddy, Cork, Ireland, P43R298
Company Detail Path: /organization/biomarin-international-limited

Company Information

Pharmaceutical Company Name: Biomarin International Limited
Country Name: Australia

Active Ingredients

SAPROPTERIN DIHYDROCHLORIDE

100 MG / SACHET

Authorized

Quick Info

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

c12f04551fae8433

Type

Standard

Back to Health Canada Approvals

KUVAN - Health Canada Drug Approval Details